Methods for producing cytokine-induced killer cells for chemotherapy
KR20190003581A
Composition for preventing skin regeneration and aging comprising peripheral blood mononuclear cells and platelet-rich plasma and skin regeneration method using same
WO2017183942A2
Peptide having efficacy of increasing collagen generation and composition comprising same
US2019142894A1
Peptide having effects of increasing telomerase activity and extending telomere, and composition containing same
WO2017119756A1
Wrinkle-improving, anti-aging, whitening, anti-inflammatory functional novel peptide, and composition containing same
WO2017116138A1
Melanin-inhibiting peptide and composition containing same
JP2018100243A
Dendritic cell therapeutic agent and immunotherapeutic agent comprising peptide derived from telomerase, and therapeutic methods using the same
KR20170054310A
Dendritic Cell Therapeutic Agent and Immunotherapeutic Agent Comprising a Peptide Derived from Telomerase, and Method for Treatment Using the Same
WO2017078440A1
Peptide having neuronal loss prevention and regeneration effects, and composition containing same
CN107847551A
Peptide with antivirus action and include its composition
WO2016190660A1
Novel peptide and composition containing the same
US2018036384A1
Peptide for preventing hearing loss, and composition comprising same
KR20160140147A
Compositions and methods for treating and preventing injury by reperfusion after ischemia in heart
KR20160126519A
A Peptide having impotence treatment activity and the Composition Comprising the Same
EP3130345A1
Peptide having fibrosis inhibitory activity and composition containing same
KR20160076911A
Peptides for treating ophthalmopathy and the Composition Comprising the Same
KR20160076556A
A peptide for keeping function of ovaries and the composition comprising the same
